Micross Supports Spectradyne in Fighting COVID-19


Share this article:

More info:

Info
 

Orlando, FL (May 1, 2020) - Micross Components remains fully operational and ready to assist our customers in providing essential products & services during this challenging time. We are very pleased to announce that Micross is supporting customers like Spectradyne (www.nanoparticleanalyzer.com), who has commercialized a technology for counting and sizing biological nanoparticles including viruses such as SARS-CoV-2. Micross AIT is utilizing their wafer level microfabrication capabilities to help create a portion of the microfluidic cartridge which is utilized in Spectradyne's particle analyzer.  Spectradyne's technology is used by companies and research institutions that are working directly on Coronavirus research and the development of vaccines. We are so grateful for this opportunity to support Spectradyne and their technology initiative to help bring this pandemic to an end.

 

About Micross

Micross (www.micross.com) is the global one-source provider of mission-critical microelectronic components and services, including Bare Die & Wafers, Advanced Interconnect Technology, Custom Packaging & Assembly, Component Modification Services, Electrical & Environmental Testing and Hi-Rel Products to manufacturers and users of semiconductor devices. In business for more than 40 years, Micross’ extensive hi-reliability capabilities serve the Aerospace & Defense, Space, Medical and Industrial markets, among others. Micross possesses the sourcing, packaging, assembly, engineering, test and logistics expertise needed to support an application throughout its entire program cycle.

About AIT (Advanced Interconnect Technology)

https://www.micross.com/advanced-services/advanced-interconnect-technology/

 

Contact: Valerie Thomas, Micross Components

Valerie.Thomas@micross.com

Related Links: https://www.micross.com

Privacy Policy

By using this online service you accept the handling of any personal data in accordance with the Privacy Policy.

Accept